Medical castration in the treatment of widespread cancers of the prostate. The role of buserelin

Medical castration with LHRH agonists is a significant trend in the treatment of locally advanced and metastatic prostate cancer (PC). The article is devoted to the effectiveness of synthetic LHRH agonist buserelin (Buserelin-depo) in the treatment of patients with hormone dependent PC. Administrati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: SV Mishugin, AA Mordovin, AA Gritskevich, IG Rusakov
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2014-12-01
Colecção:Медицинский совет
Assuntos:
рак предстательной железы
медикаментозная кастрация
агонисты лгрг
бусерелин
prostate cancer
medical castration
lhrh agonists
buserelin
Acesso em linha:https://www.med-sovet.pro/jour/article/view/612
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados